Exclusion of patentability of embryonic stem cells in Europe: another restriction by the European Patent Office

Jan 6, 2015

Authors: A. Mahalatchimy, E. Rial-Sebbag, A.- M. Duguet, A. Cambon-Thomsen, F. Taboulet.

Article in the European Intellectual Property Review, 2015, vol. 37, n°1, pp. 25- 28.

On February 4, 2014, the European Patent Office decided to follow the Court of Justice of the European Union regarding the exclusion of patentability of human embryonic stem cells (hESC), when stating that it is not acceptable to patent inventions using hESC obtained either by de novo destruction of human embryos, or from publicly available hESC lines initially derived by a process destroying the human embryo.

Part of this work is supported by the EUCelLEX project.